177,95 €
177,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
89 °P sammeln
177,95 €
177,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
89 °P sammeln
Als Download kaufen
177,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
89 °P sammeln
Jetzt verschenken
177,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
89 °P sammeln
  • Format: PDF

Nanoneuroscience, nanoneurosurgery, and nanobioelectronics have revolutionized medicine and improved the prevention, diagnosis, and treatment of neurological disorders. The Textbook of Nanoneuroscience and Nanoneurosurgery, 2nd edition presents a state-of-the-art review of the field, providing current information about nanoplatforms and their use in neurosurgery, neurology, neuroscience, and neuroradiology. The text also reviews the latest regulatory guidelines that influence the translation of nanotechnological research from the laboratory to the clinic, as well as the most recent information…mehr

  • Geräte: PC
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 105.16MB
Produktbeschreibung
Nanoneuroscience, nanoneurosurgery, and nanobioelectronics have revolutionized medicine and improved the prevention, diagnosis, and treatment of neurological disorders. The Textbook of Nanoneuroscience and Nanoneurosurgery, 2nd edition presents a state-of-the-art review of the field, providing current information about nanoplatforms and their use in neurosurgery, neurology, neuroscience, and neuroradiology. The text also reviews the latest regulatory guidelines that influence the translation of nanotechnological research from the laboratory to the clinic, as well as the most recent information on biodevices and pharmaceutical spinoffs. It highlights presidential and congressional initiatives and programs that may significantly impact the field in the near future. Chapters discuss the latest science and technologies¿which are applied to diagnosis and treatment of neurological disorders¿as well as regulatory issues that impact product development. This volume describes advances that have already been translated to the clinic or hold significant promise for future application in nanoneurosurgery, as well as their potential impact. A full-color text, the book contains contributions by more than 120 researchers, original and descriptive illustrations, and more than 3,000 references. Offering broad coverage of nanotechnological applications in diverse areas and addressing FDA regulation and healthcare policy,The Textbook of Nanoneuroscience and Nanoneurosurgery provides a foundation of ideas and methods for scientists and physicians to devise successful, less invasive procedures for future treatment of nervous system disorders.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Babak Kateb, MD, PhD, is the Founding Chairman of the Board, C.E.O., and Scientific Director of the Society for Brain Mapping and Therapeutics (S.B.M.T.), President and Scientific Director of World Brain Mapping Foundation, Pacific Palisades, CA, U.S.A., Director of the National Center for Nano-Bio-Electronics (N.C.N.B.E.), CA, U.S.A., Director of Brain Technology and Innovation Park (B.T.I.P.), Los Angeles, U.S.A., Chairman, Neuroscience20 (Brain, Spine, Mental Health) Initiative, C.E.O. and Co-founder, Aramis Therapeutics John D. Heiss, MD, is the Head of the Clinical Unit of the Surgical Neurology Branch and Program Director of the Neurological Surgery Residency Training Program at the National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (N.I.H.) in Bethesda, Maryland. He is actively involved in clinical and translational research to improve the understanding and treatment of Chiari I malformation, syringomyelia, pain, brain tumors, and Parkinson's disease. He is board-certified in neurological surgery and an expert in supervising and conducting clinical trials for C.N.S. disorders. Dr. Heiss received his B.S. in Biomedical Sciences and M.D. from the University of Michigan. In addition, he completed his surgical internship and residency in neurosurgery at the University of Cincinnati College of Medicine. Before joining NINDS, Dr. Heiss was Co-Director of the Neuroscience Intensive Care Unit at the University of Cincinnati. John S. Yu, MD, is a Professor of Neurosurgery, Vice Chair of the Department of Neurosurgery for Neurosurgical Oncology, and the Surgical Director for Neuro-Oncology at Cedars-Sinai, Los Angeles. He also serves as a Member of the Cedars-Sinai Cancer Institute, Los Angeles, U.S.A. Dr. Yu went to Harvard Medical School and then residency at Massachusetts General Hospital. Ming Hsieh, M.S.E.E., PhD, is the Chairman of the Board, President, and C.E.O. Fulgent Genetics. Before that, he served as C.E.O., President, and Chairperson of the board of directors of Cogent, Inc., a biometric identification services and products company. Before his tenure at Cogent, he founded and served as Vice President of A.M.A.X. Technology. Dr. Hsieh currently serves on the board of directors of Fortinet, Inc., a network security company traded on the Nasdaq Global Select Market. Dr. Hsieh received a B.S.E.E. from the University of Southern California in 1983, an M.S.E.E. from the University of Southern California in 1984, and honorary doctoral degrees from the University of Southern California in 2010 and the University of West Virginia in 2011. Dr. Hsieh has been a trustee at the University of Southern California since 2007 and Fudan University in China since 2011. In 2015, Dr. Hsieh was elected to the National Academy of Engineering and the National Academy of Inventors in 2017. Assistant Editors Kevin Morris. M.B.B.S. * Academic Affairs Director, Advisory Board Member, and Senior Research Scientist, Society for Brain Mapping and Therapeutics (S.B.M.T.), Pacific Palisades, U.S.A. Joe F. Bolanos, MD * Chief Operating Officer, Advisory Board Member, and Senior Research Scientist, Society for Brain Mapping and Therapeutics (S.B.M.T.), Pacific Palisades, U.S.A.